Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Cellpath Ltd. is currently navigating the Chemistry & Materials technology area with a portfolio that includes 1 pending office action. This specific matter is being handled by a distinct examiner, which indicates a highly focused prosecution effort. Because the workload is situated within a distinct art unit, the company only needs to address the procedural requirements and technical standards of a specialized group at the patent office.
The busiest examiner for this portfolio is MUTREJA, JYOTI NAGPAUL, who is responsible for 1 busiest_examiner_pending office action. Having this individual as the point of contact for the pending workload allows for a consistent and direct dialogue between the applicant and the examiner. This streamlined interaction can be beneficial for the company, as it eliminates the need to manage conflicting feedback from multiple officials.
Practitioners should note that the concentration of the portfolio under MUTREJA, JYOTI NAGPAUL in the chemistry and materials sector suggests a clear path for prosecution. With the pending office action workload being so centralized, the applicant can focus their resources on the specific concerns raised by this examiner. This structure avoids the complexities often found in larger portfolios that are spread across various examiners and art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUTREJA, JYOTI NAGPAUL | 1 | 81.1% | +4.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18100328 | Cassette Assembly | MUTREJA, JYOTI NAGPAUL | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18100328 | Cassette Assembly | MUTREJA, JYOTI NAGPAUL | 1798 | §103 | Final Rejection | 4d overdue | Pending | Jan 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCellpath Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jyoti Nagpaul Mutreja has the most, with 1 of Cellpath Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
